✦ LIBER ✦

O-287 Phase 2 study of TLK286 (GST P1-1 activated glutathione analog) administered weekly in patients with platinum refractory of resistant non-small cell lung cancer (NSCLC)

✍ Scribed by Papadimitrakopoulou, Vassiliki; Blumenschein, George; Fossella, Frank; Figlin, Robert; Gilitz, Barbara; Garland, Linda; Von Hoff, Daniel; King, Lisa; Jameson, Anneliese; Brown, Gail L.

Book ID: 118571677
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 376 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91945-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 study of TLK286 (GST P1-1 activa

Phase 2 study of TLK286 (GST P1-1 activated glutathione analog) in patients with non-small cell lung cancer who failed prior platinum-based regimens

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Phase 2 Study of TLK286 (GST P1-1 Activa

Phase 2 Study of TLK286 (GST P1-1 Activated Glutathione Analog) in patients with platinum and paclitaxel refractory/resistant advanced epithelial ovarian cancer

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Multi-institutional phase 2 study of TLK

Multi-institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer

✍ J.J. KAVANAGH; D.M. GERSHENSON; H. CHOI; L. LEWIS; K. PATEL; G.L. BROWN; A. GARC 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

O-286 A phase II efficacy study of brost

O-286 A phase II efficacy study of brostallicin, a novel minor groove binder (MGB), in patients (Pts) with platinum refractory or resistant non-small cell lung cancer (NSCLC)

✍ Sandler, A.; Natale, R.; Blajman, C.; Kalemkerian, G.; Drinkard, L.; Fein, L.; C 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 179 KB

I-99. A phase II efficacy study of brost

I-99. A phase II efficacy study of brostallicin, a novel minor groove binder (MGB), in patients with platinum refractory or resistant non-small cell lung cancer (NSCLC)

✍ Sandler, A.; Natale, R.; Blajman, C.; Kalemkerian, G.; Drinkard, L.; Fein, L.; C 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 74 KB